Sign In
Buy INNPF
$2.09
-0.310 (-12.92%)
At Close: Jun 22, 2026
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 24, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), hereby announces the filin
Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals
04:00pm, Friday, 03'rd Sep 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that
Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021
04:00pm, Friday, 27'th Aug 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 27, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") reports today, that since Janu
Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University
03:00am, Wednesday, 18'th Aug 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that,
Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)
02:53am, Tuesday, 03'rd Aug 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to issue an updat
Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss
04:00pm, Wednesday, 28'th Jul 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") filed a patent application for i
Former Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee
03:00am, Wednesday, 14'th Jul 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the addit
Innocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms
04:00pm, Friday, 09'th Jul 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") announces the filing of an intern
Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement for Poland
03:00am, Thursday, 01'st Jul 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 1, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that it h
Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness Solution
04:00pm, Wednesday, 16'th Jun 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 16, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce today th
Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturizer and Lubricant Treatment
04:00pm, Monday, 14'th Jun 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is honored to announce it has fi
Herzliya, Israel and Calgary Alberta--(Newsfile Corp. - June 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that a re
Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference
04:00pm, Wednesday, 09'th Jun 2021
Iris Bincovich, CEO will participate on the "CBD Treatments" discussion panel on Monday June 14 at 11:00AM ET.Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 9, 2021) - Innocan Pharma Co
Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study
03:28am, Friday, 14'th May 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce today tha
Innocan Pharma Engages Lytham Partners to Lead Investor Relations and Shareholder Communication Program
04:00pm, Monday, 10'th May 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 10, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") today announced it has retained L
